The dopamine D1 receptor (D1R), a class A rhodopsin-like GPCR, is one such receptor that has emerged as a promising target for the treatment of numerous psychiatric disorders [3], as it is known to play a key role in cognitive and locomotive processes [4,5]. The gene discussed is DRD1; the disease is psychiatric disorder.